Order results by:
| Issue | Title | |
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Free circulating miRNA as a potential diagnostic marker in multiple sclerosis (review) | Abstract similar documents |
| M. A. Omarova, M. S. Kozin, A. N. Boyko | ||
| "... response of patients with low levels of miR-142-3p in CSF to dimethyl fumarate was higher than in patients ..." | ||
| Vol 14, No 2 (2022) | Changes in expression of miRNAs from the DLK1-DIO3 locus are characteristic of relapsing-remitting multiple sclerosis regardless of the disease activity | Abstract similar documents |
| N. M. Baulina, A. R. Kabaeva, A. N. Boyko, O. O. Favorova | ||
| "... , separately for men and women. Patients and methods. Analysis of miR-431-5p, miR-127-3p, miR-379, miR-376c ..." | ||
| Vol 17, No 2 (2025) | Differences in cerebrospinal fluid microRNA profiles in patients with remitting multiple sclerosis and patients with other neurological diseases | Abstract similar documents |
| М. А. Omarova, М. S. Kozin, А. N. Boyko | ||
| "... Objective: to compare microRNA profiles in cerebrospinal fluid (CSF) of patients with remitting ..." | ||
| Vol 10, No 3 (2018) | MicroRNA expression profile in patients in the early stages of ischemic stroke | Abstract similar documents |
| I. S. Zhanin, V. A. Gusar, A. T. Timofeeva, V. G. Pinelis, A. Yu. Asanov | ||
| "... and/or prognostic factors of stroke, was compiled. The investigation showed a decrease in let-7i-3p and miR-23a-3p ..." | ||
| Vol 15 (2023): (Suppl. 1) | MicroRNAs as biomarkers of multiple sclerosis progression | Abstract similar documents |
| N. M. Baulina, I. S. Kiselev, O. G. Kulakova, E. V. Popova, O. O. Favorova, A. N. Boyko | ||
| "... тактики лечения и оценке его эффективности. МикроРНК (miRNAs) представляют собой короткие (21–25 ..." | ||
| Vol 10, No 4 (2018) | The brain’sglymphatic system:physiological anatomy and clinical perspectives | Abstract similar documents |
| V. N. Nikolenko, M. V. Oganesyan, N. N. Yakhno, E. A. Orlov, E. E. Porubayeva, E. Yu. Popova | ||
| "... fluid and soluble compounds from the central nervous system into cerebrospinal fluid (CSF), which ..." | ||
| Vol 13, No 6 (2021) | Changes in retinal structures as markers of multiple sclerosis progression | Abstract similar documents |
| M. O. Poplyak, A. G. Trufanov, A. V. Temniy, D. S. Maltsev, O. B. Chakchir, A. V. Mikheev, D. I. Skulyabin, G. N. Bisaga, I. V. Litvinenko, M. M. Odinak | ||
| "... -прогрессирующем (ВПРС) фенотипах РС. Пациенты и методы. Обследовано 80 пациентов: с РРС (n=48) и ВПРС (n=32 ..." | ||
| Vol 16 (2024): (Suppl. 2) | Analysis of the experience with once-weekly intramuscular administration of interferon beta-1a in the Russian population of patients with relapsing-remitting multiple sclerosis | Abstract similar documents |
| F. A. Khabirov, E. V. Granatov, A. Ya. Dykhanov, T. I. Khaibullin | ||
| "... ), которая максимально выражена в случае начальной терапии ремиттирующего РС (РРС) с низкой или умеренной ..." | ||
| Vol 16, No 6 (2024) | Evaluation of the content of microbial metabolites in cerebrospinal fluid of individuals with radiologically isolated syndrome | Abstract similar documents |
| M. A. Omarova, O. G. Zhilenkova, A. N. Boyko | ||
| "... , such as cerebrospinal fluid (CSF). In our previous studies, we have already analyzed the CSF in different variants of MS ..." | ||
| Vol 14, No 2 (2022) | New potential biomarkers of Alzheimer's disease: markers of endothelial dysfunction and neuroinflammation. | Abstract similar documents |
| A. K. Minochkin, V. Yu. Lobzin, N. N. Suchentseva, O. S. Popov, S. V. Apalko, S. G. Sherbak | ||
| "... fluid (CSF) in patients with AD and indicators of neuropsychological testing. Patients and methods. 52 ..." | ||
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Results of a study of the quality of life in patients with highly active multiple sclerosis in Russia | Abstract similar documents |
| A. N. Boiko, K. Z. Bakhtiyarova, M. A. Sherman, Z. A. Goncharova, I. V. Smagina, T. I. Khaibullin, N. N. Babicheva, N. N. Spirina, I. A. Yampolskaya-Gosteva, I. A. Sokolova, I. V. Greshnova, V. E. Nikitenkova, I. G. Lukashevich, A. V. Inzhinova, N. A. Malkova, D. S. Korobko, O. V. Boyko, I. S. Lozovskaya | ||
| "... течением ремиттирующего РС (РРС). Пациенты и методы. В исследование были включены данные о 518 пациентах из ..." | ||
| Vol 6, No 3 (2014) | Visual evoked potentials in examining the visual analyzer in patients with multiple sclerosis | Abstract similar documents |
| S. M. Karpov, Z. B. Pazhigova, E. N. Karpova | ||
| "... заболевания с учетом клинической формы составила: при ремиттирующем РС (РРС) – 3,3±2,2 года, при вторично ..." | ||
| Vol 11, No 1 (2019) | Cerebrospinal fluid biomarkers in idiopathic normal pressure hydrocephalus | Abstract similar documents |
| B. G. Adleyba, G. V. Gavrilov, A. V. Stanishevsky, B. V. Gaydar, D. V. Svistov, V. Yu. Lobzin, K. A. Kolmakova | ||
| "... (CSF) biomarkers in the differential diagnosis of iNPH and comorbidities at early stages. Objective ..." | ||
| Vol 16, No 3 (2024) | Concentration of immunoglobulin free light chains in cerebrospinal fluid in the diagnosis of multiple sclerosis | Abstract PDF (Eng) similar documents |
| Sh. R. Nabiev, S. A. Dzhukkaeva, M. Sh. Asvedov, D. E. Prokhorov, E. V. Popova, V. V. Grinyuk, P. R. Magomadova, A. R. Apevalova, O. N. Voskresenskaya | ||
| "... of immunoglobulin free light chains (FLCs) in cerebrospinal fluid (CSF) in the diagnosis and differential diagnosis ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Microbiota markers level in the cerebrospinal fluid of patients with multiple sclerosis and radiologically isolated syndrome | Abstract similar documents |
| A. N. Boyko, M. V. Melnikov, O. V. Boyko, A. R. Kabaeva, M. A. Omarova, O. G. Zhilenkova, A. M. Zatevalov, V. S. Rogovskii | ||
| "... on microbiota markers in the cerebrospinal fluid (CSF) of patients with MS and predisposing conditions ..." | ||
| Vol 16 (2024): (Suppl. 2) | Combined analysis of free kappa chains and central vein sign increases the specificity of multiple sclerosis diagnosis | Abstract similar documents |
| Sh. R. Nabiev, S. A. Dzhukkaeva, M. Sh. Asvedov, D. E. Prokhorov, E. V. Popova, V. V. Grinyuk, P. R. Magomadova, A. R. Apevalova, O. N. Voskresenskaya | ||
| "... vein sign (CVS) and the concentration of free kappa chains (FKC) in cerebrospinal fluid (CSF ..." | ||
| Vol 16, No 2 (2024) | Effects of rehabilitation on functional independence in daily life, exercise tolerance and quality of life in patients with relapsing-remitting multiple sclerosis | Abstract similar documents |
| Ya. G. Pekhova, M. Yu. Martynov, I. A. Belayeva, A. S. Ryabov, A. A. Vershinin, A. N. Boiko | ||
| "... склерозом (РРС) в стадии ремиссии. Материал и методы. Обследовано 38 пациентов с РРС (33 женщины и 5 мужчин ..." | ||
| Online-first | The first experience with the use of ofatumumab for the treatment of pediatric multiple sclerosis in real-life clinical practice in Russia. A case series | Abstract similar documents |
| E. D. Kuzminykh, V. M. Lebedev, V. E. Senchenko, M. S. Cherepyansky, V. A. Gonchar, D. S. Korobko | ||
| "... офатумумаба у пациентов младше 18 лет с ремиттирующим типом течения РС (РРС). В первом наблюдении пациентка ..." | ||
| Vol 17, No 1 (2025) | The first experience with the use of ofatumumab for the treatment of pediatric multiple sclerosis in real-life clinical practice in Russia. A case series | Abstract similar documents |
| E. D. Kuzminykh, V. M. Lebedev, V. E. Senchenko, M. S. Cherepyansky, V. A. Gonchar, D. S. Korobko | ||
| "... офатумумаба у пациентов младше 18 лет с ремиттирующим типом течения РС (РРС). В первом наблюдении пациентка 16 ..." | ||
| Vol 16, No 3 (2024) | Biological markers of Alzheimer's disease in cerebrospinal fluid: clinical and laboratory comparisons | Abstract similar documents |
| K. V. Shevtsova, D. O. Rozhkov, D. A. Grishina, V. V. Grinyuk, V. V. Zakharov, N. M. Kashakanova, N. N. Koberskaya, O. V. Kosivtsova, A. B. Lokshina, Yu. A. Starchina, A. Yu. Tyurina, A. Yu. Fedorova, V. A. Parfenov | ||
| "... , detection of biological markers (biomarkers) of AD in the cerebrospinal fluid (CSF) is of great importance ..." | ||
| Vol 17, No 3 (2025) | Structure of the subarachnoid lymphatic-like membrane as a meningeal selective barrier and immunological regulator | Abstract similar documents |
| V. N. Nikolenko, M. V. Oganesyan, K. I. Urazmetova, N. A. Rizaeva, M. V. Sankova, А. V. Moiseeva, A. A. Moiseenko, A. A. Belichenko, A. T. Nikitina, L. A. Gridin | ||
| "... the subarachnoid space. It performs critical functions including immune cell regulation, cerebrospinal fluid (CSF ..." | ||
| Vol 17, No 1 (2025) | Subjective and functional cognitive impairment: diagnostics using biological markers of Alzheimer's disease | Abstract PDF (Eng) similar documents |
| V. A. Parfenov, D. A. Grishina, A. B. Lokshina, V. V. Zakharov, K. V. Shevtsova, Ya. I. Chervyakova | ||
| "... ) at the SCI stage using biological markers for AD in cerebrospinal fluid (CSF). The article presents ..." | ||
| Vol 10, No 1S (2018): СПЕЦВЫПУСК: ЭПИЛЕПСИЯ | The role of neuroinflammation in the pathogenesis of epilepsy | Abstract similar documents |
| L. V. Lipatova, N. B. Serebryanaya, N. A. Sivakova | ||
| "... ) and controlled epilepsy (n = 80)) and 30 apparently healthy donors. The blood and cerebrospinal fluid (CSF ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Attitude to reproduced disease modifying therapies in patients with relapsing-remitting multiple sclerosis: results of a medical and sociological study | Abstract similar documents |
| Ya. V. Vlasov, M. V. Churakov, E. V. Sineok, A. N. Boyko | ||
| "... %) пациентов с ремиттирующим РС (РРС) не прекращали прием препарата после замены; о прекращении приема ..." | ||
| Vol 16, No 3 (2024) | Experience of cladribine tablets usage in the treatment of multiple sclerosis in the Multiple Sclerosis Centre of the Khanty-Mansi Autonomous Area — Yugra | Abstract similar documents |
| A. A. Sokolova, L. I. Anischenko, L. S. Zemlyanushin, E. A. Rubtsova | ||
| "... Кладрибин — таблетированный препарат для лечения ремиттирующего рассеянного склероза (РРС ..." | ||
| Vol 5, No 4 (2013) | Value of determining the cerebrospinal fluid protein markers of amyloidosis and neurodegeneration in the diagnosis of vascular and neurodegenerative cognitive impairments | Abstract similar documents |
| Vladimir Yuryevich Lobzin, A Yu Emelin, M M Odinak, L A Alekseeva, N E Monakhova | ||
| "... ) and the specific features of their transformation to dementia. Cerebrospinal fluid (CSF) was investigated in 60 ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Comparison of medical and social characteristics and quality of life of patients with primary- and secondary-progressive multiple sclerosis | Abstract similar documents |
| Ya. V. Vlasov, N. G. Polyarnaya, A. N. Boyko | ||
| "... высокий уровень усталости по сравнению с больными ремиттирующим РС (РРС). Другим неблагоприятным типом ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Clinical presentation and course of multiple sclerosis in patients with herpesvirus infection | Abstract similar documents |
| M. S. Gris, N. S. Baranova, N. N. Spirin, D. S. Kasatkin, D. V. Kiselev, E. G. Shipova | ||
| "... detected, in some patients – blood and cerebrospinal fluid (CSF) polymerase chain reaction, serum and CSF ..." | ||
| Vol 17, No 3 (2025) | Mild cognitive impairment due to cerebrovascular disease and Alzheimer’s | Abstract similar documents |
| V. A. Parfenov, D. A. Grishina, A. B. Lokshina, V. V. Grinyuk, V. V. Zakharov, K. V. Shevtsova | ||
| "... as the cause of MCI, biological markers in the cerebrospinal fluid (CSF) can be used, such as low Aβ42 levels ..." | ||
| 1 - 29 of 29 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
